首页> 外文期刊>Macromolecules >Analytical and Simulation-Based Models for Drug Release and Gel-Degradation in a Tetra-PEG Hydrogel Drug-Delivery System
【24h】

Analytical and Simulation-Based Models for Drug Release and Gel-Degradation in a Tetra-PEG Hydrogel Drug-Delivery System

机译:四聚乙二醇水凝胶药物递送系统中药物释放和凝胶降解的基于分析和仿真的模型

获取原文
获取原文并翻译 | 示例
           

摘要

We have recently reported drug-releasing, degradable Tetra-PEG hydrogels as a new drug delivery system. The gels contain two self-cleaving beta-eliminative linkers: one that covalently tethers the drug to the gel and releases it at a predictable rate, and another with slower cleavage that is installed in each cross-link of the polymer to control gel degradation. By balancing the two cleavage rates, the system can be designed to discharge most or all of the drug before the gel undergoes significant degradation. If polymer degradation is too rapid, undesirable gel-fragments covalently bound to the drug are released; if too slow, the gel remains in the body as an inert substance for prolonged periods. Here, we describe an analytical theory as well as a Monte Carlo simulation of concurrent drug release from and degradation of Tetra-PEG polymers. Considerations are made for an ideal network as well as networks containing missing bonds and double link defects. The analytical and simulation approaches are in perfect agreement with each other and with experimental data in the regime of interest. Using these models, we are able to (a) compute the time courses of drug release and gel degradation as well as the amount of fragment-drug conjugate present at any time and (b) estimate the rate constants of drug release and gel degradation necessary to control each of the above. We can also account for the size-dependent elimination of gel fragments from a localized semipermeable compartment and hence estimate fragment mass vs time curves in such in vivo compartments. The models described allow design of an optimal Tetra-PEG drug delivery vehicle for a particular use.
机译:我们最近报道了释放药物,可降解的Tetra-PEG水凝胶作为一种新的药物递送系统。凝胶包含两个自裂解的β-消除接头:一个将药物共价束缚在凝胶上并以可预测的速率释放,另一个在聚合物的每个交联中安装较慢的裂解以控制凝胶降解。通过平衡两个裂解速率,可以将系统设计为在凝胶发生明显降解之前释放出大部分或全部药物。如果聚合物降解太快,则会释放出与药物共价结合的不良凝胶碎片;如果速度太慢,凝胶会长期作为惰性物质保留在体内。在这里,我们描述了从Tetra-PEG聚合物中同时释放和降解药物的分析理论以及Monte Carlo模拟。考虑了理想的网络以及包含缺失的键和双链路缺陷的网络。分析和模拟方法彼此之间以及与感兴趣范围内的实验数据完全吻合。使用这些模型,我们能够(a)计算药物释放和凝胶降解的时间过程以及随时存在的碎片-药物结合物的量,并且(b)估计所需的药物释放和凝胶降解的速率常数来控制以上各项。我们还可以解释从局部半透性隔室中凝胶碎片的大小依赖性消除,因此可以估算此类体内隔室中的碎片质量与时间的关系曲线。所描述的模型允许设计用于特定用途的最佳Tetra-PEG药物递送载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号